Last reviewed · How we verify
P-OM3
At a glance
| Generic name | P-OM3 |
|---|---|
| Also known as | Lovaza |
| Sponsor | Provident Clinical Research |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- An Open-label Extension to Assess the Continued Efficacy of Omacor Plus Simvastatin (PHASE4)
- Effects of Prescription Omega-3 on LDL-C in Primary Hypercholesterolemia (PHASE4)
- Vascular and Lipid Effects of Omega-3 Fatty Acids in People With Moderately Elevated Triglycerides (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |